Literature DB >> 2028447

Cofactor dependent and cofactor independent anticardiolipin antibodies.

L W Chamley1, E J McKay, N S Pattison.   

Abstract

Two distinct types of anticardiolipin antibodies are described, one of which requires the presence of a serum factor (cofactor) to bind cardiolipin in ELISA and liposome affinity systems. The second type does not require this cofactor. The requirement of a cofactor for the binding of some but not all anticardiolipin antibodies provides an explanation for the confounding variability of the results of assays for these antibodies. It also explains why blocking agents such as BSA and gelatin do not produce consistent results in this assay.

Mesh:

Substances:

Year:  1991        PMID: 2028447     DOI: 10.1016/0049-3848(91)90106-7

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  6 in total

1.  False negative results of anticardiolipin antibody test.

Authors:  S Kobayashi; M Tanaka; H Tsuda; H Hashimoto; S Hirose; T Saikawa; K Yoshida
Journal:  Ann Rheum Dis       Date:  1993-02       Impact factor: 19.103

2.  Anti-phospholipid antibodies and CD5+ B cells in HIV infection.

Authors:  T Grünewald; G R Burmester; W Schüler-Maué; F Hiepe; F Buttgereit
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

3.  Conformationally altered beta 2-glycoprotein I is the antigen for anti-cardiolipin autoantibodies.

Authors:  L W Chamley; A M Duncalf; B Konarkowska; M D Mitchell; P M Johnson
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

4.  Antı-β2 Glycoprotein I Antibodies in Children with Rheumatologic Disorders.

Authors:  Elif Azarsiz; Gamze Eman; Sanem Eren Akarcan; Ezgi Ulusoy Severcan; Neslihan Karaca; Guzide Aksu; Necil Kutukculer
Journal:  Indian J Clin Biochem       Date:  2017-11-10

5.  Measurement of antiphospholipid antibody by ELISA using purified beta 2-glycoprotein I in preeclampsia.

Authors:  T Yamamoto; S Yoshimura; Y Geshi; Y Sasamori; S Okinaga; T Kobayashi; H Mori
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

6.  Cytomegalovirus-Associated Venous and Arterial Thrombotic Disease.

Authors:  Amar H Kelkar; Brian L Loc; Michael D Tarantino; Anita Rajasekhar; Huaping Wang; Mona Kelkar; John Farrell
Journal:  Cureus       Date:  2020-12-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.